Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations.

Emily S Wan, Ana Kantorowski, Madeline Polak, Reema Kadri, Caroline R Richardson, David R Gagnon, Eric Garshick, Marilyn L Moy
Author Information
  1. Emily S Wan: Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Channing Division of Network Medicine, Brigham & Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  2. Ana Kantorowski: Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  3. Madeline Polak: Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA.
  4. Reema Kadri: Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA.
  5. Caroline R Richardson: Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA.
  6. David R Gagnon: Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA; Massachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, MA, USA.
  7. Eric Garshick: Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Channing Division of Network Medicine, Brigham & Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  8. Marilyn L Moy: Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: marilyn.moy@va.gov.

Abstract

BACKGROUND: Technology-based physical activity (PA) interventions have been shown to improve daily step counts and health-related quality of life, but their effect on long-term clinical outcomes like acute exacerbations (AEs) is unknown in persons with COPD.
METHODS: U.S. Veterans with stable COPD were randomized (1:1) to either pedometer alone (control) or pedometer plus a website with feedback, goal-setting, disease education, and a community forum (intervention) for 3 months. AEs were assessed every 3 months over a follow-up period of approximately 15 months. Pedometer-assessed daily step counts, health-related quality-of-life (HRQL), and self-efficacy were assessed at baseline, end-of-intervention at 3 months, and during follow-up approximately 6 and 12 months after enrollment. Zero-inflated Poisson models assessed the effect of the intervention on risk for AEs, compared to controls. Generalized linear mixed-effects models for repeated measures examined between-group and within-group changes in daily step count, HRQL, and self-efficacy.
RESULTS: There were no significant differences in age, FEV% predicted, baseline daily step count, AEs the year prior to enrollment, or duration of follow-up between the intervention (n = 57) and control (n = 52) groups. The intervention group had a significantly reduced risk of AEs (rate ratio = 0.51, [95%CI 0.31-0.85]), compared to the control group. There were no significant between-group differences in change in average daily step count, HRQL, or self-efficacy at 6 and 12 months after enrollment.
CONCLUSIONS: A 3-month internet-mediated, pedometer-based PA intervention was associated with reduced risk for AEs of COPD over 12-15 months of follow-up. ClinicalTrials.gov identifier: NCT01772082.

Keywords

Associated Data

ClinicalTrials.gov | NCT01772082

References

  1. Respir Med. 2015 Jan;109(1):112-21 [PMID: 25499548]
  2. Physiotherapy. 2019 Mar;105(1):90-97 [PMID: 30316548]
  3. Int J Chron Obstruct Pulmon Dis. 2015 Jun 08;10:1061-73 [PMID: 26089656]
  4. PLoS One. 2013 Apr 04;8(4):e60400 [PMID: 23593211]
  5. Ann Am Thorac Soc. 2018 Apr;15(4):470-478 [PMID: 29283670]
  6. Ann Am Thorac Soc. 2015 Mar;12(3):349-56 [PMID: 25568929]
  7. Chest. 2014 Mar 1;145(3):542-550 [PMID: 24091482]
  8. Chest. 2015 Jul;148(1):128-137 [PMID: 25811395]
  9. Eur Respir J. 2016 Oct;48(4):1019-1029 [PMID: 27587557]
  10. BMC Pulm Med. 2014 Feb 03;14:12 [PMID: 24491137]
  11. Respir Med. 2018 Aug;141:1-6 [PMID: 30053953]
  12. BMC Pulm Med. 2015 Nov 04;15:136 [PMID: 26530543]
  13. Respir Med. 2012 Jul;106(7):962-9 [PMID: 22521225]
  14. J Cardiopulm Rehabil Prev. 2018 Sep;38(5):333-341 [PMID: 29757825]
  15. Ann Am Thorac Soc. 2014 Jun;11(5):695-705 [PMID: 24713094]
  16. Eur Respir J. 2018 Oct 18;52(4): [PMID: 30166322]
  17. Int J Chron Obstruct Pulmon Dis. 2009;4:301-13 [PMID: 19750190]
  18. Thorax. 2013 Oct;68(10):962-3 [PMID: 23604460]
  19. ERJ Open Res. 2016 Mar 17;2(1): [PMID: 27730174]
  20. J Med Internet Res. 2016 Aug 08;18(8):e215 [PMID: 27502583]
  21. Respir Med. 2017 Sep;130:102-110 [PMID: 29206627]
  22. Heart Lung. 2007 May-Jun;36(3):205-16 [PMID: 17509427]
  23. Chron Respir Dis. 2013;10(4):207-13 [PMID: 24177682]
  24. Thorax. 2017 May;72(5):415-423 [PMID: 28137918]
  25. Chest. 2011 Aug;140(2):331-342 [PMID: 21273294]
  26. Eur Respir J. 2015 Feb;45(2):347-54 [PMID: 25261324]
  27. Am Rev Respir Dis. 1992 Jun;145(6):1321-7 [PMID: 1595997]
  28. JAMA. 2014 Jan 8;311(2):183-92 [PMID: 24399557]
  29. J Behav Med. 2019 Dec;42(6):1082-1090 [PMID: 30980223]
  30. J Med Internet Res. 2015 Jul 24;17(7):e184 [PMID: 26209025]
  31. Respir Med. 2014 Apr;108(4):628-37 [PMID: 24451438]
  32. Natl Vital Stat Rep. 2018 Jul;67(5):1-76 [PMID: 30248015]

Grants

  1. IK2 RX002165/RRD VA

MeSH Term

Actigraphy
Aged
Disease Progression
Female
Follow-Up Studies
Humans
Internet
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive
Quality of Life
Risk
Self Efficacy
Time Factors
Walking

Word Cloud

Created with Highcharts 10.0.0monthsAEsinterventiondailystepCOPDfollow-upcontrol3assessedHRQLself-efficacyenrollmentriskcountactivityPAcountshealth-relatedeffectexacerbationspedometerapproximatelybaseline612modelscomparedbetween-groupsignificantdifferencesgroupreducedBACKGROUND:Technology-basedphysicalinterventionsshownimprovequalitylifelong-termclinicaloutcomeslikeacuteunknownpersonsMETHODS:USVeteransstablerandomized1:1eitheralonepluswebsitefeedbackgoal-settingdiseaseeducationcommunityforumeveryperiod15Pedometer-assessedquality-of-lifeend-of-interventionZero-inflatedPoissoncontrolsGeneralizedlinearmixed-effectsrepeatedmeasuresexaminedwithin-groupchangesRESULTS:ageFEV%predictedyearpriordurationn = 57n = 52groupssignificantlyrateratio = 051[95%CI031-085]changeaverageCONCLUSIONS:3-monthinternet-mediatedpedometer-basedassociated12-15ClinicalTrialsgovidentifier:NCT01772082Long-termeffectsweb-basedpedometer-mediatedExacerbationsPhysicalRandomizedcontrolledtrial

Similar Articles

Cited By